Reply to: "Risk factors of hepatocellular carcinoma after hepatitis B surface antigen seroclearance"

被引：0
|
作者：
Yip, Terry Cheuk-Fung [1 ,2 ]
Chan, Henry Lik-Yuen [1 ,2 ,3 ]
Wong, Vincent Wai-Sun [1 ,2 ,3 ]
Wong, Grace Lai-Hung [1 ,2 ,3 ]
机构：
[1] Chinese Univ Hong Kong, Inst Digest Dis, Hong Kong, Hong Kong, Peoples R China
[2] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China
[3] Chinese Univ Hong Kong, State Key Lab Digest Dis, Hong Kong, Hong Kong, Peoples R China
来源：
JOURNAL OF HEPATOLOGY | 2018年 / 68卷 / 01期
关键词：
CARRIERS; SCORES;
D O I：
10.1016/j.jhep.2017.08.026
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：208 / 209
页数：3
相关论文
共 50 条
  • [31] Letter: older age and male gender increase the risk of hepatocellular carcinoma after hepatitis B surface antigen (HBsAg) seroclearance
    Zhang, X. -Y.
    Jia, R. -R.
    Xiang, X.
    Gong, W. -F.
    Xiang, B. -D.
    Zhong, J. -H.
    Li, L. -Q
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 46 (09) : 906 - 908
  • [32] Letter: hepatitis B surface seroclearance does reduce the risk of hepatocellular carcinoma
    Chen, Y. C.
    Liaw, Y. F.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 44 (02) : 210 - 211
  • [33] Hepatocellular carcinoma in patients with prior hepatitis B surface antigen seroclearance - The coast is not clear
    Chang, P. E. J.
    Ong, W. C.
    Tan, C. K.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S142 - S142
  • [34] Liver fibrosis burden determines risk of hepatocellular carcinoma among patients with hepatitis B surface antigen seroclearance
    Mak, Lung Yi Loey
    Cheung, Ka-Shing
    Hui, Rex Wan-Hin
    Wong, Danny Ka-Ho
    Fung, Yan Yue James
    Yuen, Man-Fung
    Seto, Wai-Kay
    JOURNAL OF HEPATOLOGY, 2022, 77 : S273 - S274
  • [35] Enhanced Liver Fibrosis Score Stratifies Hepatocellular Carcinoma Risk in Patients With Hepatitis B Surface Antigen Seroclearance
    Mak, Lung-Yi
    Cheung, Ka-Shing
    Hui, Rex Wan-Hin
    Wong, Danny Ka-Ho
    Fung, James
    Yuen, Man-Fung
    Seto, Wai-Kay
    CLINICAL INFECTIOUS DISEASES, 2022, 75 (12) : 2257 - 2259
  • [36] Persistence of intrahepatic hepatitis B virus DNA integration in patients developing hepatocellular carcinoma after hepatitis B surface antigen seroclearance
    Jang, Jeong Won
    Kim, Jin Seoub
    Kim, Hye Seon
    Tak, Kwon Yong
    Nam, Heechul
    Sung, Pil Soo
    Bae, Si Hyun
    Choi, Jong Young
    Yoon, Seung Kew
    Roberts, Lewis R.
    CLINICAL AND MOLECULAR HEPATOLOGY, 2021, 27 (01) : 207 - 218
  • [37] Hepatitis B e antigen and the risk of hepatocellular carcinoma - Reply
    Chen, CJ
    Yang, HI
    You, SL
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (21): : 1722 - 1722
  • [38] EXTREMELY RARE RISK OF HEPATOCELLULAR CARCINOMA AFTER SPONTANEOUS AND NUCLEOS(T) IDE ANALOGUE INDUCED HEPATITIS B SURFACE ANTIGEN SEROCLEARANCE
    Yoo, Sunghwan
    Lee, Jung Il
    Lee, Kwan-Sik
    Lee, Hyun Woong
    HEPATOLOGY, 2022, 76 : S1394 - S1395
  • [39] Association Between Fatty Liver and Cirrhosis, Hepatocellular Carcinoma, and Hepatitis B Surface Antigen Seroclearance in Chronic Hepatitis B
    Li, Jie
    Yang, Hwai-, I
    Yeh, Ming-Lun
    Le, Michael H.
    Le, An K.
    Yeo, Yee Hui
    Dai, Chia-Yen
    Barnett, Scott
    Zhang, Jian Q.
    Huang, Jee-Fu
    Trinh, Huy N.
    Wong, Christopher
    Wong, Clifford
    Hoang, Joseph K.
    Cheung, Ramsey
    Yu, Ming-Lung
    Nguyen, Mindie H.
    JOURNAL OF INFECTIOUS DISEASES, 2021, 224 (02): : 294 - 302
  • [40] Therapy of Hepatitis B: Is It Really Not Associated With Hepatitis B Surface Antigen Seroclearance? Reply
    Yeo, Yee Hui
    Nguyen, Mindie H.
    GASTROENTEROLOGY, 2019, 157 (01) : 267 - 268
12345